Gyre Therapeutics (GYRE) Current Deferred Revenue (2010 - 2025)
Gyre Therapeutics' Current Deferred Revenue was $14,000 in Q4 2025, down 77.0% from $61,000 a year earlier and down 75.9% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Current Deferred Revenue (2010 - 2025) Analysis & Trends
From Q4 2010 onward, Gyre Therapeutics has reported Current Deferred Revenue for 38 quarters.
- Current Deferred Revenue shows a five-year compound annual growth rate of -62.9% (FY2020 to FY2025).
- In earlier years, Current Deferred Revenue was $61,000 in FY2024 (+56.4%), $39,000 in FY2023 (-73.1%), $145,000 in FY2022 (-37.0%) and $230,000 in FY2021 (-88.4%).
- The Q4 2025 figure marks the lowest quarterly Current Deferred Revenue in data going back to Q4 2010.
- Compared with a year earlier, Current Deferred Revenue was higher in two of the last four quarters, with growth averaging 5.1%.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q2 2021 (growth of 517.6%); the worst was Q4 2021 (a decline of 88.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 39,000.00 |
| Dec 31, 2022 | 145,000.00 |
| Dec 31, 2021 | 230,000.00 |
| Sep 30, 2021 | 853,000.00 |
| Jun 30, 2021 | 2.04 Mn |
| Mar 31, 2021 | 1.33 Mn |
| Dec 31, 2020 | 1.98 Mn |
| Sep 30, 2020 | 764,000.00 |
| Jun 30, 2020 | 330,000.00 |
| Dec 31, 2019 | 15.00 Mn |
| Dec 31, 2017 | 212,000.00 |
| Sep 30, 2017 | 530,000.00 |
| Jun 30, 2017 | 848,000.00 |
API Access
Gyre Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();